Literature DB >> 25689535

Small colony variants of Pseudomonas aeruginosa in chronic bacterial infection of the lung in cystic fibrosis.

Thomas J Evans.   

Abstract

Pseudomonas aeruginosa is the most common pathogen that colonizes the lungs of patients with cystic fibrosis. Isolates from sputum are typically all derived from the same strain of bacterium but show extensive phenotypic heterogeneity. One of these variants is the so-called small colony variant, which also shows increased ability to form a biofilm and is frequently resistant to multiple antibiotics. The presence of small colony variants in the sputum of patients with cystic fibrosis is associated with a worse clinical condition. The underlying mechanism responsible for generation of the small colony phenotype remains unclear, but a final common pathway would appear to be elevation of intracellular levels of cyclic di-GMP. This phenotypic variant is thus not just a laboratory curiosity, but a significant bacterial adaptation that favors survival within the lung of patients with cystic fibrosis and contributes to the pulmonary damage caused by P. aeruginosa.

Entities:  

Keywords:  Pseudomonas aeruginosa; antibiotic resistance; biofilm; bronchiectasis; cystic fibrosis; exopolysaccharide; lung infection; small colony variant

Mesh:

Substances:

Year:  2015        PMID: 25689535     DOI: 10.2217/fmb.14.107

Source DB:  PubMed          Journal:  Future Microbiol        ISSN: 1746-0913            Impact factor:   3.165


  34 in total

Review 1.  Roles of two-component regulatory systems in antibiotic resistance.

Authors:  Aimee Rp Tierney; Philip N Rather
Journal:  Future Microbiol       Date:  2019-05-08       Impact factor: 3.165

2.  The Extracellular Polysaccharide Matrix of Pseudomonas aeruginosa Biofilms Is a Determinant of Polymorphonuclear Leukocyte Responses.

Authors:  Morten Rybtke; Peter Østrup Jensen; Claus Henrik Nielsen; Tim Tolker-Nielsen
Journal:  Infect Immun       Date:  2020-12-15       Impact factor: 3.441

3.  Small Colony Variants of Pseudomonas aeruginosa Display Heterogeneity in Inhibiting Aspergillus fumigatus Biofilm.

Authors:  Rajesh Anand; Richard B Moss; Gabriele Sass; Niaz Banaei; Karl V Clemons; Marife Martinez; David A Stevens
Journal:  Mycopathologia       Date:  2017-08-07       Impact factor: 2.574

4.  Genomic Analysis Identifies Novel Pseudomonas aeruginosa Resistance Genes under Selection during Inhaled Aztreonam Therapy In Vivo.

Authors:  Kathryn McLean; Duankun Lee; Elizabeth A Holmes; Kelsi Penewit; Adam Waalkes; Mingxin Ren; Samuel A Lee; Joseph Gasper; Colin Manoil; Stephen J Salipante
Journal:  Antimicrob Agents Chemother       Date:  2019-08-23       Impact factor: 5.191

Review 5.  Cystic Fibrosis and Pseudomonas aeruginosa: the Host-Microbe Interface.

Authors:  Sankalp Malhotra; Don Hayes; Daniel J Wozniak
Journal:  Clin Microbiol Rev       Date:  2019-05-29       Impact factor: 26.132

6.  Pyrimidine Biosynthesis Regulates the Small-Colony Variant and Mucoidy in Pseudomonas aeruginosa through Sigma Factor Competition.

Authors:  Roy Al Ahmar; Brandon D Kirby; Hongwei D Yu
Journal:  J Bacteriol       Date:  2018-12-07       Impact factor: 3.490

Review 7.  Recent perspectives on the molecular basis of biofilm formation by Pseudomonas aeruginosa and approaches for treatment and biofilm dispersal.

Authors:  Sinosh Skariyachan; Vaishnavi Sneha Sridhar; Swathi Packirisamy; Supreetha Toplar Kumargowda; Sneha Basavaraj Challapilli
Journal:  Folia Microbiol (Praha)       Date:  2018-01-19       Impact factor: 2.099

8.  Induction of Native c-di-GMP Phosphodiesterases Leads to Dispersal of Pseudomonas aeruginosa Biofilms.

Authors:  Jens Bo Andersen; Kasper Nørskov Kragh; Louise Dahl Hultqvist; Morten Rybtke; Martin Nilsson; Tim Holm Jakobsen; Michael Givskov; Tim Tolker-Nielsen
Journal:  Antimicrob Agents Chemother       Date:  2021-03-18       Impact factor: 5.191

9.  Activity of Antibiotics against Pseudomonas aeruginosa in an In Vitro Model of Biofilms in the Context of Cystic Fibrosis: Influence of the Culture Medium.

Authors:  Yvan Diaz Iglesias; Françoise Van Bambeke
Journal:  Antimicrob Agents Chemother       Date:  2020-03-24       Impact factor: 5.191

10.  Rampant prophage movement among transient competitors drives rapid adaptation during infection.

Authors:  Christopher W Marshall; Erin S Gloag; Christina Lim; Daniel J Wozniak; Vaughn S Cooper
Journal:  Sci Adv       Date:  2021-07-16       Impact factor: 14.136

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.